1. Academic Validation
  2. Sumatranins A-J: Lignans with Immunosuppressive Activity from Cleistanthus sumatranus

Sumatranins A-J: Lignans with Immunosuppressive Activity from Cleistanthus sumatranus

  • J Nat Prod. 2023 Jun 23;86(6):1606-1614. doi: 10.1021/acs.jnatprod.3c00300.
Jun-Su Zhou 1 Jia-Ying Yao 2 3 Yuan Gao 1 Qun-Fang Liu 1 Bin Zhou 1 4 Shi-Jun He 3 Jin-Xin Zhao 1 4 Jian-Min Yue 1 4
Affiliations

Affiliations

  • 1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, People's Republic of China.
  • 2 College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, 818 Meiling Avenue, Nanchang, Jiangxi 330004, People's Republic of China.
  • 3 Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, People's Republic of China.
  • 4 Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, 198 East Binhai Road, Yantai, Shandong 264117, People's Republic of China.
Abstract

Chemical investigation of the twigs of Cleistanthus sumatranus (Phyllanthaceae) led to the isolation of 10 undescribed Lignans, sumatranins A-J (1-10). Compounds 1-4 are unprecedented furopyran Lignans characterized by a unique 2,3,3a,9a-tetrahydro-4H-furo[2,3-b]chromene heterotricyclic framework. Compounds 9 and 10 are rare 9'-nor-dibenzylbutane Lignans. Structures were established based on analyses of spectroscopic data, X-ray crystallographic data, and experimental ECD spectra. Immunosuppressive assays revealed compounds 3 and 9 displayed moderate inhibitory effects with good selectivity indexes against LPS-induced B lymphocyte proliferation.

Figures